Hutchinson-Gilford Progeria Syndrome (HGPS) is an extremely rare genetic disorder characterized by premature ageing in childhood and serves as a valuable model for the human ageing process in general. Most recently, point mutations in the lamin A (LMNA) gene on chromosome 1q have been associated with the disease, however how these mutations relate to the complex phenotype of HGPS remains to be established. It has been shown that fibroblasts from HGPS patients are frequently resistant to immortalization with telomerase (hTERT), consistent with the idea that the loss of a dominant acting HGPS gene is a pre-requisite for immortalization. In this study we report the first detailed cytogenetic analysis of hTERT-immortalised HGPS cell lines from three patients and one corresponding primary fibroblast culture. Our results provide evidence for a cytogenetic mosaicism in HGPS with a distinctive pattern of chromosome aberrations in all the HGP clones. Chromosome 11 alterations were observed at a high frequency in each immortalised HGPS cell line but were also present at a lower frequency in the corresponding primary cells. Moreover, we were able to identify the 11q13→q23 region as a potential site of breakage. Our results are therefore consistent with a role of chromosome 11 alterations in the escape from senescence observed in HGPS cells. In addition to this defined rearrangement, we consistently observed complex chromosomal rearrangements, suggesting that HGPS displays features of chromosomal instability.   

1.
Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, Greider CW, Harley CB: Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 89:10114–10118 (1992).
2.
Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE: Extension of life-span by introduction of telomerase into normal human cells. Science 279:349–352 (1998).
3.
Bridger JM, Kill IR: Aging of Hutchinson-Gilford progeria syndrome fibroblasts is characterised by hyperproliferation and increased apoptosis. Exper Geront 39:717–724 (2004).
4.
Burke B, Stewart CL: Life at the edge: the nuclear envelope and human disease. Nat Rev Mol Cell Biol 3:575–585 (2002).
5.
Corso C, Parry EM: The application of comparative genomic hybridization and fluorescence in situ hybridization to the characterization of genotoxicity screening tester strains AHH-1 and MCL-5. Mutagenesis 14:417–26 (1999).
6.
DeBusk FL: The Hutchinson-Gilford progeria syndrome. Report of 4 cases and review of the literature. J Pediatr 80:697–724 (1972).
7.
Delgado Luengo W, Rojas Martinez A, Ortiz Lopez R, Martinez Basalo C, Rojas-Atencio A, Quintero M, Borjas L, Morales-Machin A, Gonzalez Ferrer S, Pineda Bernal L, Canizalez-Tarazona J, Pena J, Delgado Luengo J, Chacin Hernandez J, Chong Chang J: Del(1)(q23) in a patient with Hutchinson-Gilford progeria. Am J Med Genet 113:298–301 (2002).
8.
De Sandre-Giovannoli A, Chaouch M, Kozlov S, Vallat JM, Tazir M, et al: Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse. Am J Hum Genet 70:726–736 (2002).
9.
Edelmann L, Spiteri E, McCain N, Goldberg R, Pandita RK, Duong S, Fox J, Blumenthal D, Lalani SR, Shaffer LG, Morrow BE: A common breakpoint on 11q23 in carriers of the constitutional t(11;22) translocation. Am J Hum Genet 65:1608–1616 (1999).
10.
Egorov EE, Terekhov SM, Vishniakova KS, Karachentsev DN, Kazimirchuk EV, Tsvetkova TG, Veiko NN, Smirnova TD, Makarenkov AS, El’darov MA, Meshcheriakova A, Liapunova NA, Zelenin AV: Telomerization as a method of obtaining immortal human cells preserving normal properties. Ontogenez 34:183–192 (2003).
11.
Eriksson M, Brown WT, Gordon LB, Glynn MW, Singer J, Scott L, Erdos MR, Robbins CM, Moses TY, Berglund P, Dutra A, Pak E, Durkin S, Csoka AB, Boehnke M, Glover TW, Collins FS: Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature 423:293–298 (2003).
12.
Faragher RG: Cell senescence and human aging: where’s the link? Biochem Soc Trans 28:221–226 (2000).
13.
Hutchinson CJ: Lamins: building blocks or regulators of gene expression? Nat Rev Mol Cell Biol 3:848–858 (2002).
14.
ISCN 1995: An International System for Human Cytogenetic Nomenclature, Mitelman F (ed) (S. Karger, Basel 1995).
15.
Iselius L, Lindsten J, Aurias A, Fraccaro M, Bastard C, et al: The 11q;22q translocation: a collaborative study of 20 new cases and analysis of 110 families. Hum Genet 64: 343–355 (1983).
16.
Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D: Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258 818–821 (1992).
17.
Leach DR: Long DNA palindromes, cruciform structures, genetic instability and secondary structure repair. Bioessays 16:893–900 (1994).
18.
Lo AW, Sprung CN, Fouladi B, Pedram M, Sabatier L, Ricoul M, Reynolds GE, Murnane JP: Chromosome instability as a result of double-strand breaks near telomeres in mouse embryonic stem cells. Mol Cell Biol 22:4836–4850 (2002).
19.
Ly DH, Lockhart DJ, Lerner RA, Schultz PG: Mitotic misregulation and human aging. Science 287:2486–2492 (2000).
20.
Martin GM, Oshima J: Lessons from human progeroid syndromes. Nature 408:263–266 (2000).
21.
McClintock B: The stability of broken ends of chromosome in Zea mays. Genetics 26:234–282 (1941).
22.
McSharry BP, Jones CJ, Skinner JW, Kipling D, Wilkinson GW: Human telomerase reverse transcriptase-immortalized MRC-5 and HCA2 human fibroblasts are fully permissive for human cytomegalovirus. J Gen Virol 82:855–863 (2001).
23.
Mounkes LC, Kozlov S, Hernandez L, Sullivan T, Stewart CL: A progeroid syndrome in mice is caused by defects in A-type lamins. Nature 423:298–301 (2003).
24.
Mukherjee AB, Costello C: Aneuploidy analysis in fibroblats of human premature aging syndrome by FISH during in vitro cellular aging. Mech Ageing Dev 103:209–222 (1998).
25.
Ouellette MM, McDaniel LD, Wright WE, Shay JW, Schultz RA: The establishment of telomerase-immortalized cell lines representing human chromosome instability syndromes. Hum Mol Genet 9:403–11 (2000).
26.
Rainbow AJ, Howes M: Decreased repair of gamma ray damaged DNA in progeria. Biochem Biophys Res Commun 74:714–719 (1977).
27.
Richardson C, Moynahan ME, Jasin M: Double-strand break repair by interchromosomal recombination: suppression of chromosomal translocations. Genes Dev 12:3831–3842 (1998).
28.
Speicher MR, Gwyn Ballard S, Ward DC: Karyotyping human chromosomes by combinatorial multi-fluor FISH. Nat Genet 12:368–375 (1996).
29.
Veldman T, Vignon C, Schrock E, Rowley JD, Ried T: Hidden chromosome abnormalities in haematological malignancies detected by multicolour spectral karyotyping. Nat Genet 15:406–410 (1997).
30.
Wallis C, Sheerin, A, Green MHL, Jones, CJ, Kipling D, Faragher RA: Fibroblast clones from patients with Hutchinson-Gilford progeria can senesce despite the presence of telomerase. Exp Gerontol 39:461–467 (2004).
© 2005 S. Karger AG, Basel
2005
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.